Candid Therapeutics, Inc. — Form D

Candid Therapeutics, Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2024-09-13. The offering totals $206.2M, of which $206.2M was reported sold. Industry: Other Health Care.

Offering

• Filed: 2024-09-13
• Form: D
• Accession: 0002035778-24-000001
• Industry: Other Health Care
• Exemptions: 06b
• Total offering: $206.2M
• Amount sold: $206.2M
• Investors: 33
• Date of first sale: 2024-08-19
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-524038

Issuer

• Name: Candid Therapeutics, Inc.
• CIK: 0002035778
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2024
• Address: 11622 EL CAMINO REAL, SUITE 150, SAN DIEGO, CA, 92130
• Phone: 858-247-0550

Officers, directors & promoters (8)

More

• CIK 2035778 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search